Press Release Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update Taysha Gene Therapies, Inc. · Aug 11
Press Release Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights Maze Therapeutics, Inc. · Aug 11
Press Release Mobile Infrastructure Reports Second Quarter 2026 Financial Results Mobile Infrastructure · Aug 11
Press Release Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1 Belite Bio, Inc · Aug 11
Press Release BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress TheRas, Inc. (d/b/a BBOT) · Aug 11
Press Release Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Mineralys Therapeutics, Inc. · Aug 11
Press Release BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) BridgeBio Pharma, Inc. · Aug 11
Press Release Black Rock Coffee Bar, Inc. Reports Second Quarter 2026 Results Black Rock Coffee Bar, Inc. · Aug 11
Press Release GrowGeneration Reports Second Quarter 2026 Financial Results GrowGeneration Corp. · Aug 11